NPPES file of Aug 9, 2026

James Mark Cleary, MD/PHD

Medical Oncology Physician · Boston, MA

James Mark Cleary, MD/PHD is a medical oncology physician with a practice address in Boston, Massachusetts, and NPI 1922062397, issued on Apr 13, 2006. Check the license (Massachusetts 226742, as entered in NPPES) on the Massachusetts Board of Registration in Medicine; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1922062397
Name
James Mark Cleary
Credential
MD/PHD
Primary taxonomy
Medical Oncology Physician 207RX0202X
License number
226742 MA
Self-reported in NPPES; status is on the state search
Practice location
44 Binney St, Boston, MA 02115
Phone
(617) 632-3000
Enumerated
Apr 13, 2006
Record last updated
Feb 17, 2010 (not updated in 16 years: call before relying on the address or phone)
Medicare enrollment
Enrolled (PECOS I20100421000769); accepts Medicare assignment
Medical or professional school
Albert Einstein College Of Medicine Of Yeshiva University, 2003
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 44 Binney St

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Karim Abou-Nassar, MDHematology & Oncology Physician1366770745
  2. Janet Abrahm, MDMedical Oncology Physician1427024264
  3. Thomas Abrams, M.D.Medical Oncology Physician1184693947
  4. Christine Agius, RN, MSN, NP-C, RNCAdult Health Nurse Practitioner1932114790
  5. Laura Aguilar, MD PHDPediatric Hematology & Oncology Physician1295786598
  6. Zi Yazan Alabed, M.D., PH.D.Student in an Organized Health Care Education/Training Program1184046583

Verify James Mark Cleary in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersMassachusetts Board of Registration in Medicine
    Search for license 226742
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Massachusetts license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

66% fewer Medicare Part D claims than the average medical oncology physician in 2024

242 Medicare Part D claims for 44 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 12% of claims. 13 claims were for opioids.

  1. James Cleary242
  2. Specialty average703

Most prescribed

  1. Lorazepam28 claims
  2. Prochlorperazine Maleate22 claims
  3. Omeprazole16 claims
  4. Loperamide13 claims
  5. Olanzapine13 claims
  6. Dexamethasone12 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 86.3 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score69.4
  2. Costnot scored (reweighted)
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $9,669.50

6 payments; by number, the most common kind was consulting fee; the largest payer was AstraZeneca Pharmaceuticals LP. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. James Cleary$9,670
  2. Specialty average$11,773

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Dana-Farber Cancer Institute, Inc.Boston, MA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

James Mark Cleary among 421 medical oncology physician records in Massachusetts

James Mark Cleary, MD/PHD is one of 421 medical oncology physician records with a practice address in Massachusetts. 76% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 10% of them.

  • NPI issued2006 · 10% of these records are older, 60% newer
  • In a Medicare fileYes · 76% of these records are
  • In the CMS Doctors and Clinicians fileYes · 69% of these records are
  • Graduated2003 · median 2007 among the 291 with a school on file
  • Record last updated2010 · 51% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RX0202X and a Massachusetts practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Medical Oncology Physician providers in Massachusetts

There are 421 medical oncology physician records in Massachusetts.

The 8 medical oncology physician records with the nearest ZIP codes

  1. Janet Abrahm, MDBoston, MA 021151427024264
  2. Rameen Beroukhim, MDBoston, MA 021151083680680
  3. Craig Bunnell, MDBoston, MA 021151982679767
  4. Jennifer Chan, MDBoston, MA 021151871578823
  5. Iris Chan, MD PHDBoston, MA 021151396712105
  6. Suzanne George, MDBoston, MA 021151437126018
  7. Vincent Ho, MDBoston, MA 021151245207737
  8. Frank Hodi, MDBoston, MA 021151730156324

Common questions

What is James Mark Cleary, MD/PHD's NPI number?

James Mark Cleary, MD/PHD's National Provider Identifier (NPI) is 1922062397, issued on Apr 13, 2006. An NPI identifies a provider in billing; it is not a license.

Where is James Mark Cleary, MD/PHD located?

The NPPES record lists a practice address at 44 Binney St, Boston, MA, 02115. Phone: (617) 632-3000. Providers update this record themselves, so call before visiting.

How can I verify James Mark Cleary, MD/PHD's license?

NPPES lists Massachusetts license number 226742, as entered by the provider. Search the Massachusetts Board of Registration in Medicine at https://findmydoctor.mass.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does James Mark Cleary, MD/PHD prescribe under Medicare Part D?

In 2024, James Mark Cleary, MD/PHD had 242 Medicare Part D claims for 44 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.

What is James Mark Cleary, MD/PHD's MIPS final score?

The 2023 MIPS final score is 86.3 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.